At close: December 20 at 4:10:12 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-7,004.0100
-7,004.0100
-12,728.6590
-13,435.9370
-6,360.4380
Investing Cash Flow
-15.7980
-15.7980
-2.2990
-10.6140
4.3790
Financing Cash Flow
21,170.5350
21,170.5350
11,069.1850
17,691.0370
3,825.3090
End Cash Position
22,141.4660
22,141.4660
7,991.7920
9,629.7560
5,250.0940
Capital Expenditure
-15.7980
-15.7980
-2.2990
-10.6140
-9.5720
Issuance of Capital Stock
25,706.9270
25,706.9270
8,724.8300
20,679.8740
45.0000
Issuance of Debt
1,024.1280
--
2,842.5000
--
5,000.0000
Repayment of Debt
-2,842.5000
-2,842.5000
--
-1,700.0000
-1,072.7590
Repurchase of Capital Stock
-1,402.9640
-1,402.9640
-444.6140
-1,240.0060
--
Free Cash Flow
-7,019.8080
-7,019.8080
-12,730.9580
-13,446.5510
-6,370.0100
6/30/2021 - 7/31/1989
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ILA.AX Island Pharmaceuticals Limited
0.1800
+2.86%
PIQ.AX Proteomics International Laboratories Ltd
0.6400
+0.79%
CYP.AX Cynata Therapeutics Limited
0.2000
+2.56%
BOT.AX Botanix Pharmaceuticals Limited
0.3650
-6.41%
ACW.AX Actinogen Medical Limited
0.0250
0.00%
MDC.AX Medlab Clinical Limited
6.60
0.00%
MEM.AX Memphasys Limited
0.0050
-16.67%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0340
-8.11%
NOX.AX Noxopharm Limited
0.0950
+2.15%
1AD.AX AdAlta Limited
0.0150
0.00%